FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

New Legislation Impacting Your Profession
June 29, 2020

Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading


Reporting of COVID-19 for Health Care Providers and Facilities
April 30, 2020

COVID-19 positive patients and COVID-19 laboratory results are subject to mandatory reporting to the Florida Department of Health under Section 381.0031, Florida Statutes. Continue reading